医学
肝硬化
内科学
逻辑回归
心脏病学
队列
收缩性
心肌病
弗雷明翰风险评分
扩张型心肌病
心力衰竭
疾病
作者
M Razpotnik,Simona Bota,Philipp Wimmer,Peter Höfer,Michael Hackl,Matthias Fürstner,Hannes Alber,Raphael Mohr,Alexander Wree,Nirbaanjot Walia,Cornelius Engelmann,Münevver Demir,Frank Tacke,Markus Peck‐Radosavljevic
摘要
ABSTRACT Aim Cirrhotic cardiomyopathy is characterised by myocardial dysfunction in patients with cirrhosis in the absence of other cardiac conditions. We aimed to develop and validate a scoring system to identify patients at high risk for reduced global longitudinal strain, a newly proposed marker of myocardial dysfunction in the updated diagnostic criteria for cirrhotic cardiomyopathy. Methods Prospectively recruited patients with cirrhosis in the training and validation groups underwent identical hepatological and cardiological evaluations, including strain echocardiography. Risk factors for myocardial dysfunction were identified using logistic regression. Results In a cohort of 452 consecutive patients, 278 were excluded due to non‐cirrhotic cardiomyopathy or conditions potentially affecting strain measurements. The prevalence of reduced global longitudinal strain was 9.8% (13/133) in the training group and 19.5% (8/41) in the validation group. Multivariate logistic regression revealed BMI ≥ 28 kg/m 2 (OR 7.02), CAP > 260 dB/m (OR 8.53), and age > 57 years (OR 4.68) as independent predictors of reduced myocardial contractility. These variables were combined and weighted based on their beta coefficients to develop the Liver‐heart score (CAP > 260 dB/m [2 pts], BMI ≥ 28 kg/m 2 [2 pts], age > 57 years [1 pt]). The AUC‐ROC was 0.84 in the training and 0.83 in the validation cohort. A Liver‐heart score of 5 points was associated with increased mortality, observed at 2 years (44.4% vs. 17.3%) and the end of the follow‐up period (66.7% vs. 37.7%, HR 1.3, p < 0.01). Conclusion The Liver‐heart score can accurately rule out reduced myocardial contractility and may be useful for risk stratification in cirrhotic patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI